YURAKNING ISHEMIK KASALLIGI BOR BEMORLARDA BO’LMACHALAR FIBRILYATSIYASINING KLINIK KECHISHI
##article.subject##:
yurakning ishemik kasalligi, bo’lmachalar fibrilyasiyasining persistrlovchi shakli, kuchayib borish faktorlari##article.abstract##
Bo’lmachalar fibrilatsiyasi (BF) yurak ritmi buzilishining eng keng tarqalgan kasalliklaridan biri bo'lib, umumiy populyatsiyada 2% ni tashkil qiladi va o'sishda davom etmoqda. BF bemorlarning hayot sifatini yomonlashtiradi va umr ko'rish davomiyligini qisqartiradi. BF yurak-qon tomir kasalliklari uchun mustaqil xavf omili ekanligiga ishoniladi. BF diagnostikasi va davolash bo'yicha so'nggi tavsiyalarga ko'ra, aritmiyaning 5 turi mavjud: birinchi marta aniqlangan, paroksismal, persistrlovchi, uzoq muddat persistrlovchi va doimiy. BF bilan og'rigan bemorlarning eng katta qismi persistrlovchi yoki doimiy shaklga o'tadi, bu esa bemorlarning klinik ko'rinishi va ularning prognozining yomonlashishiga olib keladi.
Библиографические ссылки
Guidelines for management of atrial fibrillation. The task force for the management of atrial fibrillation of European Society of Cardiology (ESC). Eur. Heart J. 2013; 31(19): 2369-439.
Nabauer M., Gerth A., Limbourg T. et al. The Registry of the German Competence NET work on Atrial Fibrillation: patient characteristics and initial management. Europace 2009; 11: 423—34.
Nieuwlaat R., Capucci A., Camm A.J. et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26: 2422—34.
De Vos C.B., Pisters R., Nieuwlaat R. et al. Progression from paroxysmal to persistent atrial fibrillation. J. Am. Coll. Cardiol. 2010; 55(8): 725—31.
Holmqvist F., Kim S., Steinberg B.A. et al. Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart, 2015; 101: 894—9.
Im S.I., Chun K.J., Park S.J. et al. Long-term prognosis of paroxysmal atrial fibrillation and predictors for progression to persistnt or chronic atrial fibrillation in the Korean population. J. Korean Med. Sci. 2015; 30(7): 895—902.
Rizaeva, M. Z. (2022). The clinical course of atrial fibrillation in patients with coronary heart disease. European journal of molecular medicine, 2(1).
Rizaeva, M. Z. (2022). Efficiency and safety of electric cardioversion in persistent form of atrial fibrillation. European journal of molecular medicine, 2(5).
Пулатова, Ш. Х. (2023). A new approach to the treatment of type 2 diabetes mellitus with coronary heart disease. Узбекский медицинский журнал, (SI-1).
Ризаева, М. Ж. (2023). Трудности Свертывающей Системы У Больных С Фибрилляции Предсердий (Обзорная Статья). Miasto Przyszłości, 36, 465-469.
Sh, A. N., & Rizaeva, M. J. (2023). Problems of hemostasis in patients with persistent atrial fibrillation on the background of coronary heart disease. Eurasian Research Bulletin, 21, 1-6.
Пулатова, Ш. Х. (2012). Учредители: Институт иммунологии Академии Наук Республики Узбекистан. Теоретической и клинической медицины Учредители: Институт иммунологии Академии Наук Республики Узбекистан ISSN: 2091-5853
